{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T10:00:39Z","timestamp":1788602439464,"version":"build-2803163510"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.fct.2018.03.005","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T01:58:34Z","timestamp":1520474314000},"page":"63-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"special_numbering":"C","title":["Risk assessment of pyrrolizidine alkaloids in food of plant and animal origin"],"prefix":"10.1016","volume":"115","author":[{"given":"Birgit","family":"Dusemund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Sommerfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Lindtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Lampen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2018.03.005_bib1","series-title":"Pyrrolizidine Alkaloids in Food: a Toxicological Review and Risk Assessment","author":"ANZFA (Australia New Zealand Food Authority)","year":"2001"},{"key":"10.1016\/j.fct.2018.03.005_bib2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00103-004-0949-6","article-title":"Absch\u00e4tzung der Aufnahme von Pflanzenschutzmittel-R\u00fcckst\u00e4nden in der Nahrung mit neuen Verzehrsmengen f\u00fcr Kinder","volume":"48","author":"Banasiak","year":"2005","journal-title":"Bundesgesundheitsblatt - Gesundheitsforsch. - Gesundheitsschutz"},{"key":"10.1016\/j.fct.2018.03.005_bib3","series-title":"Salatmischung mit Pyrrolizidinalkaloid-haltigem Greiskraut verunreinigt","author":"BfR (Bundesinstitut f\u00fcr Risikobewertung)","year":"2007"},{"key":"10.1016\/j.fct.2018.03.005_bib4","series-title":"Pyrrolizidine Alkaloids in Herbal Teas and Teas","author":"BfR (Bundesinstitut f\u00fcr Risikobewertung)","year":"2013"},{"key":"10.1016\/j.fct.2018.03.005_bib5","series-title":"Analytik und Toxizit\u00e4t von Pyrrolizidinalkaloiden sowie eine Einsch\u00e4tzung des gesundheitlichen Risikos durch deren Vorkommen in Honig","author":"BfR (Bundesinstitut f\u00fcr Risikobewertung)","year":"2013"},{"key":"10.1016\/j.fct.2018.03.005_bib6","series-title":"Pyrrolizidinalkaloide: Gehalte in Lebensmitteln sollen nach wie vor so weit wie m\u00f6glich gesenkt werden","author":"BfR (Bundesinstitut f\u00fcr Risikobewertung)","year":"2016"},{"key":"10.1016\/j.fct.2018.03.005_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/path.1700900116","article-title":"Foetal and neonatal responses to hepatotoxic agents","volume":"90","author":"Bhattacharyya","year":"1965","journal-title":"J. Pathol. Bacteriol."},{"issue":"11","key":"10.1016\/j.fct.2018.03.005_bib8","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1080\/19440049.2014.964337","article-title":"Determination of pyrrolizidine alkaloids in tea, herbal drugs and honey","volume":"31","author":"Bodi","year":"2014","journal-title":"Food Addit. Contam."},{"key":"10.1016\/j.fct.2018.03.005_bib9","series-title":"Handbuch Monitoring 2017","author":"BVL (Bundesamt f\u00fcr Verbraucherschutz und Lebensmittelsicherheit: Referat 103 \u201cStrategie und Koordination in der Kontrolle\u201d)","year":"2017"},{"key":"10.1016\/j.fct.2018.03.005_bib10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0041-0101(94)90368-9","article-title":"Toxicity and carcinogenicity of riddelliine following 13 weeks of treatment to rats and mice","volume":"32","author":"Chan","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.fct.2018.03.005_bib11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.yrtph.2017.03.019","article-title":"Risk assessment for pyrrolizidine alkaloids detected in (herbal) teas and plant food supplements","volume":"86","author":"Chen","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.fct.2018.03.005_bib12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/jat.1504","article-title":"Genotoxicity of pyrrolizidine alkaloids","volume":"30","author":"Chen","year":"2010","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.fct.2018.03.005_bib13","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1021\/tx030018y","article-title":"Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid","volume":"16","author":"Chou","year":"2003","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.fct.2018.03.005_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canlet.2003.12.001","article-title":"Correlation of DNA adduct formation and riddelliine-induced liver tumorigenesis in F344 rats and B6C3F1 mice","volume":"207","author":"Chou","year":"2004","journal-title":"Canc. Lett."},{"key":"10.1016\/j.fct.2018.03.005_bib15","series-title":"Discussion Paper on Pyrrolizidine Alkaloids","author":"Codex Alimentarius Commission","year":"2011"},{"key":"10.1016\/j.fct.2018.03.005_bib16","series-title":"COT Statement on Pyrrolizidine Alkaloids in Food","author":"COT (Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment)","year":"2008"},{"key":"10.1016\/j.fct.2018.03.005_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0009-2797(76)90046-6","article-title":"Hepato- and pneumotoxicity of pyrrolizidine alkaloids and derivatives in relation to molecular structure","volume":"12","author":"Culvenor","year":"1976","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.fct.2018.03.005_bib18","first-page":"289","article-title":"Zur Toxizit\u00e4t Pyrrolizidinalkaloidhaltiger Arzneipflanzen","volume":"128","author":"Danninger","year":"1983","journal-title":"Pharm. Ztg."},{"key":"10.1016\/j.fct.2018.03.005_bib19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/19440049.2010.547520","article-title":"Pyrrolizidine alkaloids in food: a spectrum of potential health consequences","volume":"28","author":"Edgar","year":"2011","journal-title":"Food Addit. Contam."},{"key":"10.1016\/j.fct.2018.03.005_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1021\/tx500403t","article-title":"Pyrrolizidine alkaloids: potential role in the etiology of cancers, pulmonary hypertension, congenital anomalies, and liver disease","volume":"28","author":"Edgar","year":"2015","journal-title":"Chem. Res. Toxicol."},{"issue":"8","key":"10.1016\/j.fct.2018.03.005_bib21","first-page":"4572","article-title":"Dietary exposure assessment to pyrrolizidine alkaloids in the European population","volume":"14","author":"EFSA (European Food Safety Authority)","year":"2016","journal-title":"EFSA Journal"},{"key":"10.1016\/j.fct.2018.03.005_bib22","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2903\/j.efsa.2005.282","article-title":"Opinion of the Scientific Committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic","author":"EFSA (European Food Safety Authority: Scientific Committee)","year":"2005","journal-title":"The EFSA Journal"},{"issue":"1","key":"10.1016\/j.fct.2018.03.005_bib23","first-page":"4658","article-title":"Update: use of the benchmark dose approach in risk assessment","volume":"15","author":"EFSA (European Food Safety Authority: Scientific Committee)","year":"2017","journal-title":"EFSA Journal"},{"issue":"11","key":"10.1016\/j.fct.2018.03.005_bib24","first-page":"2406","article-title":"Scientific Opinion on Pyrrolizidine alkaloids in food and feed","volume":"9","author":"EFSA (European Food Safety Authority: Scientific Panel on Contaminants in the Food Chain (CONTAM))","year":"2011","journal-title":"EFSA Journal"},{"issue":"7","key":"10.1016\/j.fct.2018.03.005_bib25","first-page":"4908","article-title":"Risks for human health related to the presence of pyrrolizidine alkaloids in honey, tea, herbal infusions and food supplements","volume":"15","author":"EFSA (European Food Safety Authority: Scientific Panel on Contaminants in the Food Chain (CONTAM))","year":"2017","journal-title":"EFSA Journal"},{"key":"10.1016\/j.fct.2018.03.005_bib26","series-title":"Public Statement on the Use of Herbal Medicinal Products Containing Toxic, Unsaturated Pyrrolizidine Alkaloids (PAs)","author":"EMA (European Medicines Agency: Committee on Herbal Medicinal Products (HMPC))","year":"2014"},{"key":"10.1016\/j.fct.2018.03.005_bib27","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0022-3476(78)81227-X","article-title":"Pyrrolizidine (Senecio) intoxication mimicking Reye syndrome","volume":"93","author":"Fox","year":"1978","journal-title":"J. Pediatr."},{"key":"10.1016\/j.fct.2018.03.005_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/DMR-120028426","article-title":"Pyrrolizidine alkaloids - genotoxicity, metabolism enzymes, metabolic activation, and mechanisms","volume":"36","author":"Fu","year":"2004","journal-title":"Drug Metabol. Rev."},{"key":"10.1016\/j.fct.2018.03.005_bib29","first-page":"400","article-title":"Detection, hepatotoxicity, and tumorigenicity of pyrrolizidine alkaloids in Chinese herbal plants and herbal dietary supplements","volume":"15","author":"Fu","year":"2007","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.fct.2018.03.005_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1021\/acs.chemrestox.6b00297","article-title":"Pyrrolizidine alkaloids: metabolic activation pathways leading tolLiver tumor initiation","volume":"30","author":"Fu","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.fct.2018.03.005_bib31","first-page":"369","article-title":"Malformations in foetal rats induced by the pyrrolizidine alkaloid heliotrine","volume":"42","author":"Green","year":"1961","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.fct.2018.03.005_bib32","article-title":"Chapter 4: chemistry, biology and chemoecology of pyrrolizidine alkaloids","volume":"vol 9","author":"Hartmann","year":"1995"},{"key":"10.1016\/j.fct.2018.03.005_bib33","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1021\/tx900328f","article-title":"Glucuronidation, a new metabolic pathway for pyrrolizidine alkaloids","volume":"23","author":"He","year":"2010","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.fct.2018.03.005_bib34","series-title":"Verzehrsstudie zur Ermittlung der Lebensmittelaufnahme von S\u00e4uglingen und Kleinkindern f\u00fcr die Absch\u00e4tzung eines akuten Toxizit\u00e4tsrisikos durch R\u00fcckst\u00e4nde von Pflanzenschutzmitteln (VELS)","author":"Heseker","year":"2003"},{"key":"10.1016\/j.fct.2018.03.005_bib35","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/mnfr.201300707","article-title":"Structure-activity relationship in the passage of different pyrrolizidine alkaloids through the gastrointestinal barrier: ABCB1 excretes heliotrine and echimidine","volume":"58","author":"Hessel","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.fct.2018.03.005_bib36","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/jnci\/58.4.1155","article-title":"Carcinogenic activity of petasitenine, a new pyrrolizidine alkaloid isolated from petasites japonicus Maxim2","volume":"58","author":"Hirono","year":"1977","journal-title":"J. Natl. Cancer Inst. (Bethesda)"},{"key":"10.1016\/j.fct.2018.03.005_bib37","first-page":"469","article-title":"Induction of hepatic tumors in rats by senkirkine and symphytine","volume":"63","author":"Hirono","year":"1979","journal-title":"J. Natl. Cancer Inst. (Bethesda)"},{"key":"10.1016\/j.fct.2018.03.005_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0041-008X(03)00165-0","article-title":"Chemical-specific alterations in ras, p53, and \u03b2-catenin genes in hemangiosarcomas from B6C3F1 mice exposed to o-nitrotoluene or riddelliine for 2 years","volume":"191","author":"Hong","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.fct.2018.03.005_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1353\/pbm.1980.0078","article-title":"Herbal teas and toxins: novel aspects of pyrrolizidine poisoning in the United States","volume":"24","author":"Huxtable","year":"1980","journal-title":"Perspect. Biol. Med."},{"key":"10.1016\/j.fct.2018.03.005_bib40","article-title":"IARC Monographs on the evaluation of carcinogenic risk of chemicals to man","volume":"vol 10","author":"IARC (World Health Organization: International Agency for Research on Cancer)","year":"1976"},{"key":"10.1016\/j.fct.2018.03.005_bib41","article-title":"IARC Monogr. Eval. Carcinog. Risk Chem. Humans","volume":"vol 31","author":"IARC (World Health Organization: International Agency for Research on Cancer)","year":"1983"},{"key":"10.1016\/j.fct.2018.03.005_bib42","series-title":"IARC Monographs on the Evaluation of Carcinogenic Risks to Humans","author":"IARC (World Health Organization: International Agency for Research on Cancer)","year":"1987"},{"key":"10.1016\/j.fct.2018.03.005_bib43","article-title":"IARC Monographs on the evaluation of carcinogenic risks to humans","volume":"vol 82","author":"IARC (World Health Organization: International Agency for Research on Cancer)","year":"2002"},{"key":"10.1016\/j.fct.2018.03.005_bib44","first-page":"80","article-title":"Pyrrolizidine alkaloids","author":"IPCS\/INCHEM (World Health Organization: International Programme on Chemical Safety)","year":"1988","journal-title":"Environ. Health Criter."},{"key":"10.1016\/j.fct.2018.03.005_bib45","unstructured":"JECFA (World Health Organization: Joint FAO\/WHO Expert Committee on Food Additives) (2015). Eightieth meeting Rome, 16\u201325 June 2015. Summary and Conclusions. Issued 6 July 2015. JECFA\/80\/SC."},{"key":"10.1016\/j.fct.2018.03.005_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/313280","article-title":"An outbreak of hepatic veno-occlusive disease in Western Afghanistan associated with exposure to wheat flour contaminated with pyrrolizidine alkaloids","volume":"2010","author":"Kakar","year":"2010","journal-title":"J. Toxicol."},{"key":"10.1016\/j.fct.2018.03.005_bib47","first-page":"44","article-title":"Methoden der Nationalen Verzehrsstudie II","volume":"53","author":"Krems","year":"2006","journal-title":"Ernahrungs- Umsch."},{"key":"10.1016\/j.fct.2018.03.005_bib48","first-page":"439","article-title":"Effects of integerrimine on the implantation and intrauterine development of mice","volume":"9","author":"Kvitko","year":"1986","journal-title":"Rev. Bras. Genet."},{"key":"10.1016\/j.fct.2018.03.005_bib49","first-page":"181","article-title":"Microsomal formation of a pyrrolic alcohol glutathione conjugate of clivorine - firm evidence for the formation of a pyrrolic metabolite of an otonecine-type pyrrolizidine alkaloid","volume":"26","author":"Lin","year":"1998","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.fct.2018.03.005_bib50","first-page":"374","article-title":"Preliminary findings of chromosomal studies on rats and humans with veno-occlusive disease","volume":"53","author":"Martin","year":"1972","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.fct.2018.03.005_bib51","series-title":"Chemistry and Toxicology of Pyrrolizidine Alkaloids","author":"Mattocks","year":"1986"},{"key":"10.1016\/j.fct.2018.03.005_bib52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.canlet.2004.06.013","article-title":"Differential mutagenicity of riddelliine in liver endothelial and parenchymal cells of transgenic big blue rats","volume":"215","author":"Mei","year":"2004","journal-title":"Canc. Lett."},{"key":"10.1016\/j.fct.2018.03.005_bib53","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.bjc.6602420","article-title":"Mutagenicity of comfrey (Symphytum officinale) in rat liver","volume":"92","author":"Mei","year":"2005","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.fct.2018.03.005_bib54","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1021\/tx049955b","article-title":"Mutations induced by the carcinogenic pyrrolizidine alkaloid riddelliine in the liver cII gene of transgenic big blue rats","volume":"17","author":"Mei","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.fct.2018.03.005_bib55","first-page":"458","article-title":"The mutant frequencies and types of mutations induced by comfrey in the lungs of transgenic Big Blue rats","volume":"15","author":"Mei","year":"2007","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.fct.2018.03.005_bib56","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.toxlet.2016.05.002","article-title":"Interim relative potency factors for the toxicological risk assessment of pyrrolizidine alkaloids in food and herbal medicines","volume":"263","author":"Merz","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.fct.2018.03.005_bib57","series-title":"Nationale Verzehrsstudie II (NVS II)","author":"MRI (Max Rubner-Institut: Bundesforschungsinstitut f\u00fcr Ern\u00e4hrung und Lebensmittel)","year":"2008"},{"key":"10.1016\/j.fct.2018.03.005_bib58","series-title":"Occurrence of Pyrrolizidine Alkaloids in Food","author":"Mulder","year":"2015"},{"key":"10.1016\/j.fct.2018.03.005_bib59","series-title":"Bioassay of Lasiocarpine for Possible Carcinogenicity","author":"NCI (National Cancer Institute)","year":"1978"},{"key":"10.1016\/j.fct.2018.03.005_bib60","first-page":"825","article-title":"Hepatotoxicity of pyrrolizidine alkaloids","volume":"18","author":"Neuman","year":"2015","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.fct.2018.03.005_bib61","series-title":"NTP Technical Report on the Toxicology and Carcinogenesis Studies of Riddelliine (CAS No. 23246-96-0) in F344\/N Rats and B6C3F1 Mice (Gavage Studies)","author":"NTP (US National Toxicology Program)","year":"2003"},{"key":"10.1016\/j.fct.2018.03.005_bib62","first-page":"177","article-title":"Effect of an extract of senecio vulgaris and senecionine on rat fetuses","volume":"7","author":"Nuzzo","year":"1987","journal-title":"Toxicologist"},{"key":"10.1016\/j.fct.2018.03.005_bib63","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/taap.2002.9485","article-title":"The hepatic endothelial carcinogen riddelliine induces endothelial apoptosis, mitosis, S phase, and p53 and hepatocytic vascular endothelial growth factor expression after short-term exposure","volume":"184","author":"Nyska","year":"2002","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.fct.2018.03.005_bib64","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/path.1711310406","article-title":"Comparison of the toxic effects of dehydroheliotridine and heliotrine in pregnant rats and their embryos","volume":"131","author":"Peterson","year":"1980","journal-title":"J. Pathol."},{"key":"10.1016\/j.fct.2018.03.005_bib65","first-page":"24","article-title":"Auftreten einer Pyrrolizidinalkaloid-Zirrhose beim Rind nach Aufnahme von Senecio alpinus (Alpenkreuzkraut)","volume":"111","author":"Pohlenz","year":"1981","journal-title":"Wochenzeitschrift"},{"key":"10.1016\/j.fct.2018.03.005_bib66","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1383-5742(99)00010-1","article-title":"Pyrrolizidine alkaloids in human diet","volume":"443","author":"Prakash","year":"1999","journal-title":"Mutat. Res."},{"key":"10.1016\/j.fct.2018.03.005_bib67","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000070799","article-title":"Veno-occlusive disease in a fetus caused by pyrrolizidine alkaloids of food origin","volume":"18","author":"Rasenack","year":"2003","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/j.fct.2018.03.005_bib68","series-title":"Pyrrolizidine Alkaloids in Herbal Preparations","author":"RIVM (National Institute for Public Health and the Environment)","year":"2014"},{"key":"10.1016\/j.fct.2018.03.005_bib69","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/pauz.19840130201","article-title":"Wie verbreitet und wie gef\u00e4hrlich sind Pyrrolizidinalkaloide?","volume":"13","author":"Roeder","year":"1984","journal-title":"Pharmazie in unserer Zeit"},{"key":"10.1016\/j.fct.2018.03.005_bib70","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0022-3476(88)80330-5","article-title":"Hepatic veno-occlusive disease in newborn infant of a woman drinking herbal tea","volume":"112","author":"Roulet","year":"1988","journal-title":"J. Pediatr."},{"key":"10.1016\/j.fct.2018.03.005_bib71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1021\/tx4004159","article-title":"Lack of metabolic activation and predominant formation of an excreted metabolite of nontoxic platynecine-type pyrrolizidine alkaloids","volume":"27","author":"Ruan","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.fct.2018.03.005_bib72","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/path.1700770220","article-title":"Liver lesions in young rats suckled by mothers treated with the pyrrolizidine (Senecio) alkaloids, lasiocarpine and retrorsine","volume":"77","author":"Schoental","year":"1959","journal-title":"J. Pathol. Bacteriol."},{"key":"10.1016\/j.fct.2018.03.005_bib73","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/jnci\/56.4.787","article-title":"Neoplastic transformation in tissues of rats exposed to monocrotaline or dehydroretronecine","volume":"56","author":"Shumaker","year":"1976","journal-title":"J. Natl. Cancer Inst. (Bethesda)"},{"key":"10.1016\/j.fct.2018.03.005_bib74","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF01991912","article-title":"Reversible hepatic veno-occlusive disease in an infant after consumption of pyrrolizidine-containing herbal tea","volume":"154","author":"Sperl","year":"1995","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.fct.2018.03.005_bib75","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0016-5085(19)32224-3","article-title":"Hepatic veno-occlusive disease due to pyrrolizidine (Senecio) poisoning in Arizona","volume":"73","author":"Stillman","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2018.03.005_bib76","series-title":"Biogene Gifte - Biologie-chemie-pharmakologie-toxikologie","author":"Teuscher","year":"2010"},{"key":"10.1016\/j.fct.2018.03.005_bib77","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.toxlet.2004.11.010","article-title":"Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid","volume":"155","author":"Wang","year":"2005","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.fct.2018.03.005_bib78","series-title":"Discussion Paper on Pyrrolizidine Alkaloids. Joint FAO\/WHO Food Standards Programme. Codex Committee on Contaminants in Foods 5th Session","author":"WHO (World Health Organization)","year":"2011"},{"key":"10.1016\/j.fct.2018.03.005_bib79","series-title":"Pyrrolizidine Alkaloids. Structure and Toxicity","author":"Wiedenfeld","year":"2008"},{"key":"10.1016\/j.fct.2018.03.005_bib80","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1021\/tx025605i","article-title":"Human liver microsomal metabolism and DNA adduct formation of the tumorigenic pyrrolizidine alkaloid, riddelliine","volume":"16","author":"Xia","year":"2003","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.fct.2018.03.005_bib81","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.canlet.2005.01.023","article-title":"Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, lasiocarpine","volume":"231","author":"Xia","year":"2006","journal-title":"Canc. Lett."},{"key":"10.1016\/j.fct.2018.03.005_bib82","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1021\/acs.chemrestox.6b00120","article-title":"Pyrrolizidine alkaloid-protein adducts: potential non-invasive biomarkers of pyrrolizidine alkaloid-induced liver toxicity and exposure","volume":"29","author":"Xia","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.fct.2018.03.005_bib83","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cbi.2015.09.011","article-title":"Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity","volume":"243","author":"Yang","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.fct.2018.03.005_bib84","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1007\/s00204-017-2013-y","article-title":"First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans","volume":"91","author":"Yang","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.fct.2018.03.005_bib85","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1021\/acs.chemrestox.6b00260","article-title":"Comparative study of hepatotoxicity of pyrrolizidine alkaloids retrorsine and monocrotaline","volume":"30","author":"Yang","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.fct.2018.03.005_bib86","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/tx000150n","article-title":"Metabolic activation of the tumorigenic pyrrolizidine alkaloid, riddelliine, leading to DNA adduct formation in vivo","volume":"14","author":"Yang","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.fct.2018.03.005_bib87","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00204-016-1713-z","article-title":"The long persistence of pyrrolizidine alkaloid-derived DNA adducts in vivo: kinetic study following single and multiple exposures in male ICR mice","volume":"91","author":"Zhu","year":"2017","journal-title":"Arch. Toxicol."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691518301443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691518301443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T21:41:14Z","timestamp":1759527674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691518301443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":87,"alternative-id":["S0278691518301443"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2018.03.005","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk assessment of pyrrolizidine alkaloids in food of plant and animal origin","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2018.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}